Reproducible differentiation of pure ovarian support cells from clinical-grade hiPSCs as a novel infertility treatment
Preprint
Abstract
In vitro maturation (IVM) is an infertility treatment used during in vitro fertilization (IVF) procedures in which immature oocytes are matured outside the body, limiting the excessive hormone doses required for retrieval of ready-to-fertilize oocytes. To overcome the historically low embryo formation rate associated with IVM, we have recently demonstrated that co-culture of hiPSC-derived ovarian support cells (OSCs) yielded higher rates of oocyte maturation and euploid embryo formation, by mimicking the complex ovarian environment in vitro, offering a novel solution to overcome the IVM main limitation. To translate this process into clinics, we sourced and engineered a compliant female clinical-grade (CG) hiPSC line to derive OSCs with similar quality attributes and clinical outcomes to results previously demonstrated with a research hiPSC line. We further optimized our manufacturing protocols to enable increased scale and substituted reagents with appropriate higher-quality alternatives. This strategic approach to product development has successfully met scalable manufacturing needs and ultimately resulted in a product of improved reproducibility, purity, and efficacy. Our findings support the use of a similar strategy to fine-tune hiPSC-derived products facilitating translation to clinical applications.Keywords
This publication has 40 references indexed in Scilit:
- Outcomes of clinical in vitro maturation programs for treating infertility in hyper responders: a systematic reviewFertility and Sterility, 2023
- RNA binding protein IGF2BP1 meditates oxidative stress-induced granulosa cell dysfunction by regulating MDM2 mRNA stability in an m6A-dependent mannerRedox Biology, 2022
- Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells-based therapy productStem Cells Translational Medicine, 2020
- Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissueJournal of Assisted Reproduction and Genetics, 2020
- Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral folliclesJournal of Assisted Reproduction and Genetics, 2019
- Transcriptome Landscape of Human Folliculogenesis Reveals Oocyte and Granulosa Cell InteractionsMolecular Cell, 2018
- In vitro differentiation of human embryonic stem cells into ovarian follicle-like cellsNature Communications, 2017
- A “freeze-all” embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?Fertility and Sterility, 2013
- Bone morphogenetic protein 7 (BMP-7) increases the expression of follicle-stimulating hormone (FSH) receptor in human granulosa cellsFertility and Sterility, 2010
- N-Cadherin-Mediated Human Granulosa Cell Adhesion Prevents ApoptosisThe American Journal of Pathology, 1999